Zobrazeno 1 - 10
of 14 123
pro vyhledávání: '"AJ Lee"'
Autor:
Getaround
Publikováno v:
Business Wire (English). 03/11/2024.
Autor:
Getaround
Publikováno v:
Business Wire (English). 05/24/2023.
Publikováno v:
The Bulletin of the Royal College of Surgeons of England. 104:20-27
INTRODUCTION Successful completion of the MRCS examination is mandatory for surgical trainees in the UK. The MRCS is attempted early in surgical training, before applying for competitive entry to specialty training posts. The aim of this study was to
Publikováno v:
The Bulletin of the Royal College of Surgeons of England. 103:398-402
Background Reports of surgical training and experiences vary across the 16 UK foundation schools. Little is known about whether foundation school choice is associated with later performance in surgical training. We investigated choice of school in re
Publikováno v:
The Bulletin of the Royal College of Surgeons of England. 103:344-350
Autor:
Scaramanga, Jenna
Publikováno v:
Total Guitar; Summer2024, Issue 387, p46-49, 4p, 2 Color Photographs
Autor:
AJ Avery, C Anderson, CM Bond, H Fortnum, A Gifford, PC Hannaford, L Hazell, J Krska, AJ Lee, DJ McLernon, E Murphy, S Shakir, MC Watson
Publikováno v:
Health Technology Assessment, Vol 15, Iss 20 (2011)
Background: The monitoring of adverse drug reactions (ADRs) through pharmacovigilance is vital to patient safety. Spontaneous reporting of ADRs is one method of pharmacovigilance, and in the UK this is undertaken through the Yellow Card Scheme (YCS).
Externí odkaz:
https://doaj.org/article/a1cd7103608c456e84fdaec6a1e5ab43
Autor:
S Bhattacharya, LJ Middleton, A Tsourapas, AJ Lee, R Champaneria, JP Daniels, T Roberts, NH Hilken, P Barton, R Gray, KS Khan, P Chien, P O’Donovan, KG Cooper, International Heavy Menstrual Bleeding Individual Patient Data Meta-analysis Collaborative Group
Publikováno v:
Health Technology Assessment, Vol 15, Iss 19 (2011)
Objective: The aim of this project was to determine the clinical effectiveness and cost-effectiveness of hysterectomy, first- and second-generation endometrial ablation (EA), and Mirena® (Bayer Healthcare Pharmaceuticals, Pittsburgh, PA, USA) for th
Externí odkaz:
https://doaj.org/article/35b5373508bf4f12895317ad05405cd5
Autor:
Liu, Donghui1,2 (AUTHOR), Wang, Jiangmei1,2 (AUTHOR), Xu, Zhengzhong1,2 (AUTHOR), Chen, Xiang1,2 (AUTHOR) chenxiang@yzu.edu.cn, Jiao, Xin'an1,2 (AUTHOR)
Publikováno v:
One Health Advances. 12/23/2024, Vol. 2 Issue 1, p1-10. 10p.
Autor:
Alpysbekova, Aigerim1 (AUTHOR) aigelya@utexas.edu, Montero-Zamora, Pablo1 (AUTHOR), Soares, Mary H.2 (AUTHOR), Scaramutti, Carolina3 (AUTHOR), Sahbaz, Sumeyra1 (AUTHOR), Duque, Maria4 (AUTHOR), Bautista, Tara5 (AUTHOR), Garcia, Maria Fernanda4 (AUTHOR), Salas-Wright, Christopher P.4 (AUTHOR), Maldonado-Molina, Mildred M.6 (AUTHOR), Bates, Melissa M.7 (AUTHOR), Pérez-Gómez, Augusto6 (AUTHOR), Mejía Trujillo, Juliana6 (AUTHOR), Brown, Eric C.3 (AUTHOR), Schwartz, Seth J.1 (AUTHOR)
Publikováno v:
PLoS ONE. 12/23/2024, Vol. 19 Issue 12, p1-19. 19p.